Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
377 studies found for:    "Squamous cell carcinoma of the head and neck"
Show Display Options
Rank Status Study
21 Completed Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Gefitinib;   Drug: methotrexate
22 Active, not recruiting Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Intervention: Drug: MEDI4736
23 Completed SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention:
24 Recruiting Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Valproic Acid;   Drug: Cisplatin;   Drug: Cetuximab
25 Completed
Has Results
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Drug: 5FU
26 Completed
Has Results
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: Cetuximab;   Drug: Cisplatin;   Drug: 5-Fluorouracil
27 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
28 Active, not recruiting Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Drug: Carboplatin
29 Recruiting Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: LEE011
30 Active, not recruiting Phase II Study of RAD001 Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Everolimus 10mg daily
31 Completed Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma
Condition: Squamous Cell Carcinomas of the Head and Neck
Intervention: Procedure: Esophagoscopy and chromoendoscopy
32 Completed Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Cabazitaxel 15mg/m2;   Drug: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
33 Active, not recruiting Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: DCA (dichloroacetate);   Drug: Placebo
34 Active, not recruiting Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Radiation: 3 Dimensional Radiation Therapy;   Radiation: Intensity Modulated Radiation Therapy
35 Terminated Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma Of The Head And Neck
Interventions: Drug: Cetuximab;   Drug: Dasatinib
36 Recruiting Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Pembrolizumab;   Other: Placebo
37 Completed Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Radiation: Radiation therapy;   Radiation: definitive external beam radiation in the ipsilateral neck
38 Active, not recruiting A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: MEDI4736;   Biological: tremelimumab
39 Active, not recruiting
Has Results
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Nivolumab;   Drug: Cetuximab;   Drug: Methotrexate;   Drug: Docetaxel
40 Recruiting Preoperative Administration of Olaparib With or Without Cisplatin in Patients Who Are Candidates for Surgery of Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Olaparib;   Drug: Cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.